<p>，/PRNewswire/ -- DJS 律师事务所宣布正在代表 aTyr Pharma, Inc.（&#34;aTyr&#34;或&#34;公司&#34;）（NASDAQ: ATYR）的投资者调查索赔，涉及证券法的违反。</p>
<p><strong>调查详情：</strong> 调查重点是公司是否发布了误导性声明和/或未能披露与投资者相关的重要信息。2025 年 9 月 15 日，_路透社_报道说，&#34;aTyr Pharma 周一表示，其实验药物未能在一项针对患有肺部疾病（称为肺肉芽肿病）的患者的晚期研究中达到主要目标，该疾病影响肺部和淋巴结。&#34; 根据这一消息，aTyr 的股票在同一天的早盘交易中下跌超过 81%。</p>
<p>如果您是遭受损失的股东，请联系我们参与。</p>
<p><strong>为什么选择 DJS 律师事务所？</strong> DJS 律师事务所的主要目标是通过平衡的咨询和积极的倡导来提高投资者回报。我们专注于证券集体诉讼、公司治理诉讼以及国内/国际并购评估。我们的客户是全球一些最大和最复杂的对冲基金和另类资产管理公司。我们客户的诉讼索赔是极其有价值的资产，值得尊重、关注和结果。</p>
<p>本新闻稿在某些司法管辖区可能被视为律师广告，依据适用法律和伦理规则。</p>
<p><strong>联系方式：</strong></p>
<p>David J. Schwartz</p>
<p>DJS 律师事务所</p>
<p>274 White Plains Road, Suite 1</p>
<p>Eastchester, NY 10709</p>
<p>电话：914-206-9742</p>
<p>电子邮件：[email protected]</p>
<p>来源：DJS 律师事务所 LLP</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjA4Jk5ld3NJdGVtSWQ9TEE0MTEwNyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMDgwMzI1UFJfTkVXU19VU1BSX19fX19MQTQxMTA3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjA4Jk5ld3NJdGVtSWQ9TEE0MTEwNyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMDgwMzI1UFJfTkVXU19VU1BSX19fX19MQTQxMTA3"/></p>

LIFE

<p>DJS Law Group 正在调查 aTyr Pharma, Inc. 是否存在证券欺诈违规行为。调查的重点是 aTyr 是否发布了误导性声明或未能披露重要信息。在一项药物研究失败的消息传出后，aTyr 的股价下跌超过 81%。遭受损失的股东被鼓励联系 DJS Law Group。该公司专注于证券集体诉讼和公司治理诉讼</p>

<p>, /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of aTyr Pharma, Inc. (&#34;aTyr&#34; or &#34;the Company&#34;) (NASDAQ: ATYR) for violations of the securities laws.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- DJS 律师事务所宣布正在代表 aTyr Pharma, Inc.（&#34;aTyr&#34;或&#34;公司&#34;）（NASDAQ: ATYR）的投资者调查索赔，涉及证券法的违反。</p>
</div><p><strong>INVESTIGATION DETAILS:</strong> The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors. On September 15, 2025, <em>Reuters</em> reported that, &#34;aTyr Pharma said on Monday its experimental drug had failed to meet the main goal in a late-stage study testing it in patients with a type of lung disease known as pulmonary sarcoidosis, which impacts the lungs and lymph nodes.&#34; Based on this news, shares of aTyr traded down by more than 81% in morning trading on the same day.</p>
<div class="lb-trans"><p><strong>调查详情：</strong> 调查重点是公司是否发布了误导性声明和/或未能披露与投资者相关的重要信息。2025 年 9 月 15 日，_路透社_报道说，&#34;aTyr Pharma 周一表示，其实验药物未能在一项针对患有肺部疾病（称为肺肉芽肿病）的患者的晚期研究中达到主要目标，该疾病影响肺部和淋巴结。&#34; 根据这一消息，aTyr 的股票在同一天的早盘交易中下跌超过 81%。</p>
</div><p>If you are a shareholder who suffered a loss, contact us to participate.</p>
<div class="lb-trans"><p>如果您是遭受损失的股东，请联系我们参与。</p>
</div><p><strong>WHY DJS LAW GROUP?</strong> DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&amp;A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.</p>
<div class="lb-trans"><p><strong>为什么选择 DJS 律师事务所？</strong> DJS 律师事务所的主要目标是通过平衡的咨询和积极的倡导来提高投资者回报。我们专注于证券集体诉讼、公司治理诉讼以及国内/国际并购评估。我们的客户是全球一些最大和最复杂的对冲基金和另类资产管理公司。我们客户的诉讼索赔是极其有价值的资产，值得尊重、关注和结果。</p>
</div><p>This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.</p>
<div class="lb-trans"><p>本新闻稿在某些司法管辖区可能被视为律师广告，依据适用法律和伦理规则。</p>
</div><p><strong>CONTACT:</strong></p>
<div class="lb-trans"><p><strong>联系方式：</strong></p>
</div><p>David J. Schwartz</p>
<div class="lb-trans"><p>David J. Schwartz</p>
</div><p>DJS Law Group</p>
<div class="lb-trans"><p>DJS 律师事务所</p>
</div><p>274 White Plains Road, Suite 1</p>
<div class="lb-trans"><p>274 White Plains Road, Suite 1</p>
</div><p>Eastchester, NY 10709</p>
<div class="lb-trans"><p>Eastchester, NY 10709</p>
</div><p>Phone: 914-206-9742</p>
<div class="lb-trans"><p>电话：914-206-9742</p>
</div><p>Email: [email protected]</p>
<div class="lb-trans"><p>电子邮件：[email protected]</p>
</div><p>SOURCE DJS Law Group LLP</p>
<div class="lb-trans"><p>来源：DJS 律师事务所 LLP</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjA4Jk5ld3NJdGVtSWQ9TEE0MTEwNyZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMDgwMzI1UFJfTkVXU19VU1BSX19fX19MQTQxMTA3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA41107&amp;Transmission_Id=202512080325PR_NEWS_USPR_____LA41107&amp;DateId=20251208"/></p>

aTyr Pharma, Inc. 因涉嫌证券欺诈违规行为被调查 - 请联系 DJS 律师事务所以讨论您的权利 - ATYR